Group items tagged

The markets opened in the negative territory today. At present, both the indices are trading very flat with the Sensex down 11 points at 15959 and Nifty down by 3 points at 4775. Banking stocks were under selling pressure, falling nearly 0.5 per cent. Auto and FMCG stocks also traded lower.

http://www.StockMarketFunding.com Pt 2 Dendreon Huge Drop Down 16.4% In After-Hours Commentary (VIDEO) DNDN Trading Video Dendreon Cancer Drug Dendreon DNDN Update Dendreon's Cancer Vaccine Provenge -- Dendreon Corporation (Nasdaq:DNDN - News) announced that the Centers for Medicare and Medicaid Services (CMS) today initiated a National Coverage Analysis (NCA) of PROVENGE® (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). PROVENGE is the first in a new therapeutic class known as autologous cellular immunotherapies. In CMS's announcement of the NCA, CMS is requesting public comments on the effects of PROVENGE on health outcomes in patients with prostate cancer. It is not a change in Medicare coverage policy. NCAs do not impact existing coverage decisions, nor do they restrict local Medicare contractors from covering PROVENGE. Therefore, Medicare beneficiaries are still able to access PROVENGE and private payers can also still cover PROVENGE. Dendreon welcomes the opportunity to continue our discussions with CMS about how PROVENGE will be provided to Medicare beneficiaries, particularly given the survival benefit and safety profile of PROVENGE. We plan on continuing to work closely with CMS during this process to ensure patients with advanced prostate cancer have broad access to PROVENGE. Clinical Trial Results Supporting U.S. Food and Drug Administration (FDA) Approval

Live Trading Video FCX Trade Freeport McMoran Copper Gold Inc. FCX traded lower with the commodity sector due to a stronger dollar and weaker commodity prices. In this live options trading video we'll show you where we have our limit orders to buy the $105 December Call contract.